Latest News and Press Releases

MINNEAPOLIS, May 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to participate in the Bank of America Merrill Lynch 2012 Health Care...

Net revenue increases 12% to $23.8 million, exceeding the top end of guidance EPS increases 20% to $0.12, also exceeding the top end of guidance Raising 2012 revenue guidance to a range...

Net revenue increases 6% to $22.1 million EPS increases 8% to $0.13 Maintaining 2012 guidance for 9% revenue growth and 15% EPS growth, excluding one-time items in 2011 Finishes year...

MINNEAPOLIS, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in...

MINNEAPOLIS, Nov. 29, 2011 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 6th Annual Canaccord Genuity Cardiovascular,...

MINNEAPOLIS, Nov. 22, 2011 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 23rd Annual Piper Jaffray Health Care Conference...

Net revenue increases 22% to record $24.3 million EPS increases 144% to $0.22 Revising full-year 2011 guidance to revenues between $90.2-$90.6 million, EPS $0.56-$0.58 Establishing...

MINNEAPOLIS, Aug. 31, 2011 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the 2011 Stifel Nicolaus Healthcare Conference in...

MINNEAPOLIS, Aug. 9, 2011 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that the Company is scheduled to present at the Wedbush 2011 Life Sciences Management Access...

-       Net revenue increases 14% to record $22.3 million -        EPS increases nearly 45% to...